FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Sufia Khatun

Research Profile

Chemicals & Drugs

Disorders

Procedures

Concepts & Ideas

Survival Rate

Co-author Network

Publications

TOP 3
Jiro Fujimoto; Ikumi Aoki; Hiroshi Toyoki; Sufia Khatun; Eriko Sato; Hideki Sakaguchi; Teruhiko Tamaya
Clinical implications of expression of ETS-1 related to angiogenesis in metastatic lesions of ovarian cancers.
Sufia Khatun; Jiro Fujimoto; Hiroshi Toyoki; Teruhiko Tamaya
Clinical implications of expression of ETS-1 in relation to angiogenesis in ovarian cancers.
Jiro Fujimoto; Ikumi Aoki; Hiroshi Toyoki; Sufia Khatun; Eriko Sato; Teruhiko Tamaya
Expression of ETS-1 related to angiogenesis in uterine endometrium during the menstrual cycle.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Sufia Khatun (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2004: Jiro Fujimoto; Ikumi Aoki; Hiroshi Toyoki; Sufia Khatun; Eriko Sato; Hideki Sakaguchi; Teruhiko Tamaya
Clinical implications of expression of ETS-1 related to angiogenesis in metastatic lesions of ovarian cancers.
Oncology 2004;66(5):420-8.
2003: Sufia Khatun; Jiro Fujimoto; Hiroshi Toyoki; Teruhiko Tamaya
Clinical implications of expression of ETS-1 in relation to angiogenesis in ovarian cancers.
Cancer science 2003;94(9):769-73.
2003: Jiro Fujimoto; Ikumi Aoki; Hiroshi Toyoki; Sufia Khatun; Eriko Sato; Teruhiko Tamaya
Expression of ETS-1 related to angiogenesis in uterine endometrium during the menstrual cycle.
Journal of biomedical science 2003;10(3):320-7.
2002: Hideki Sakaguchi; Jiro Fujimoto; Ikumi Aoki; Hiroshi Toyoki; Sufia Khatun; Teruhiko Tamaya
Expression of oestrogen receptor alpha and beta in uterine endometrial and ovarian cancers.
European journal of cancer (Oxford, England : 1990) 2002;38 Suppl 6():S74-5.
2002: Jiro Fujimoto; Ikumi Aoki; Hiroshi Toyoki; Sufia Khatun; Teruhiko Tamaya
Clinical implications of expression of ETS-1 related to angiogenesis in uterine endometrial cancers.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(10):1605-11.
2002: Jiro Fujimoto; Ikumi Aoki; Hiroshi Toyoki; Sufia Khatun; Teruhiko Tamaya
Clinical implications of expression of ETS-1 related to angiogenesis in uterine cervical cancers.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(10):1598-604.
2002: Jiro Fujimoto; Ikumi Aoki; Sufia Khatun; Hiroshi Toyoki; Teruhiko Tamaya
Clinical implications of expression of interleukin-8 related to myometrial invasion with angiogenesis in uterine endometrial cancers.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(3):430-4.
2001: Jiro Fujimoto; Hideki Sakaguchi; Ikumi Aoki; Sufia Khatun; Teruhiko Tamaya
Clinical implications of expression of vascular endothelial growth factor in metastatic lesions of ovarian cancers.
British journal of cancer 2001;85(3):313-6.
2001: Jiro Fujimoto; Hideki Sakaguchi; Ikumi Aoki; Hiroshi Toyoki; Sufia Khatun; Teruhiko Tamaya
Inhibitory effect of ginsenoside-Rb2 on invasiveness of uterine endometrial cancer cells to the basement membrane.
European journal of gynaecological oncology 2001;22(5):339-41.
2000: Jiro Fujimoto; Hideki Sakaguchi; Ikumi Aoki; Sufia Khatun; Hiroshi Toyoki; Teruhiko Tamaya
Steroid receptors and metastatic potential in endometrial cancers.
The Journal of steroid biochemistry and molecular biology 2000;75(4-5):209-12.